Rex Bionics PLC (LSE:RXB) - Share price - Overview

Stock Report

Rex Bionics PLC RXB

Last Price
GBX1.75

Day Change
-0.75|-30.00%

As of 26/05/2017
08:24:42 BST | GBX
Minimum 15 Minutes Delay.

Last Close2.50p
Day Range0.50 - 1.50
Mkt Cap446,492.00
52-Wk Range0.50 - 34.50
Yield %-
ISINGB00BLRLQM66
Volume3,921
P/E-0.06
P/S0.01
P/CF-0.09

Share Price

Financials
201420152016
More ...
Income Statement
Revenue--0.45
Operating Income---5.37
Net Income---4.88
Basic EPS---0.29
Avg. Diluted Shares Outstanding--17
Balance Sheet
Current Assets--2.73
Non Current Assets--13.05
Total Assets--15.78
Current Liabilities--0.92
Total Liabilities--3.46
Total Equity--12.32
Cash Flow
Operating Cash Flow---3.71
Capital Expenditure---0.51
Free Cash Flow---4.22

In millions, except "Basic EPS". Currency is GBP.

Company Profile

Rex Bionics PLC is engaged in research & development, manufacturing and commercialisation of robotic devices designed to provide physiotherapy to and improve the physical and psychological well-being of people.

Sector

Healthcare

Industry

Medical Devices

Fiscal Year Ends

March

Employees

30
Key Stats
More ...
Price/Earning TTM-0.09
Price/Book0.05
Price/Sales TTM1.02
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-1,190.02
Net Margin % TTM-1,080.93
ROE TTM-39.56
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.